The NCI Outstanding Investigator Award (R35)

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The 2017 OIA Funding Opportunity Announcement is now available.

The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research. The OIA provides up to $600,000 in direct costs per year for 7 years, allowing substantial time for funded investigators to take greater risks and be more adventurous in their research.

Applications must be submitted by institutions that have nominated a Principal Investigator (PI) with outstanding productivity in cancer research as a recipient of NCI grant(s) for at least the past 5 years. The PI will be expected to commit at least 6 calendar months effort to the OIA; the Institution will be expected to commit at least 20% salary support.

Letter of Intent due date for 2017 award: October 22, 2016

Application due date for 2017 award: November 22, 2016, by 5:00 PM local time of applicant organization.

AIDS Application due date for the 2017 award: January 7, 2017

The Outstanding Investigator Award (R35)

NCI established the Outstanding Investigator Award (R35) in 2015 for principal investigators who have achieved significant research accomplishments. Featured in this video is Holly Prigerson, Ph.D., of Weill Cornell Medicine, who is among the first group of 62 researchers to receive the award.

  • Updated: August 22, 2016